Tenet Healthcare (THC) Tops Q2 EPS by 189c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts THC Hot Sheet
Price: $258.53 --0%
Revenue Growth %: +3.8%
Financial Fact:
Litigation and investigation costs: 4M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +3.8%
Financial Fact:
Litigation and investigation costs: 4M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $6.12, $1.89 better than the analyst estimate of $4.23. Revenue for the quarter came in at $5.63 billion versus the consensus estimate of $5.43 billion.
2026 Outlook:-
Revenue between $21.9 billion to $22.5 billion vs consensus $21.98.
EPS between $20.30 to $21.69 vs consensus $18.12.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
